Circle Pharma
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
About Circle Pharma
Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.
Company Facts
- Headquarters
- San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- late_stage_venture
- Total Funding
- $207,500,000
- Last Funding Type
- series_d
- Last Funding Date
- 2024-09-03
- Website
- circlepharma.com
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Therapeutics
Social Links
Canonical: https://fsome.com/organization/circle-pharma-113093 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.